6.8.2010
•
News
Energy
KSB advises Spolchemie in a joint venture project
Kocián Šolc Balaštík provided legal services to Spolek pro chemickou a hutní výrobu in founding a joint venture with the Japanese DIC Corporation, one of the world-wide leaders in the specialty chemicals industry.
Pursuant to a long-term cooperation agreement, Spolek pro chemickou a hutní výrobu is to produce certain chemical products in its facilities in Ústí nad Labem which the DIC Corporation has been producing elsewhere in its European facilities so far. Also Spolchemie is to be responsible for certain distribution and marketing operations relative to the products.
KSB provided full-service legal consulting throughout the entire deal, including commercial negotiations. KSB also took part in drafting the extensive contract documentation.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
